Table 3.
Comparison between groups regarding use of concomitant medications
| Concomitant medications | Induction of ventricular tachycardia / ventricular fibrillation | ||
|---|---|---|---|
| No 41 (56.4%) | Yes 31 (43.1%) | P value | |
| Beta-blocker | 15 (36.6) | 19 (61.3) | 0.06 |
| Amiodarone | 22 (53.7) | 17 (54.8) | 1.00 |
| ACE inhibitors/ABRs | 33 (80.5) | 24 (77.4) | 0.78 |
| Furosemide | 10 (24.4) | 8 (25.8) | 1.00 |
| Statins | 16 (39.0) | 5 (16.1) | 0.04 |
| Aspirin | 22 (53.7) | 8 (25.8) | 0.03 |
| OA | 2(4.9) | 0 (0.0) | 0.50 |
| Spironolactone | 8 (19.5) | 11 (35.5) | 0.18 |
ACE: angiotensin-converting enzyme: ABRs: angiotensin II receptor blockers: OA: oral anticoagulant.